Connect with us
In November, Moderna already confirmed its bad omens, recording losses of $3.6 billion in the third quarter of 2023, compared to the million dollars in revenue...
If someone told you there's a quant out there that's outperformed the S&P 500 by 475% over the last 10 years, you'd want in on the...
The pharmaceutical company Eli Lilly has added that it will invest $100 million with the aim of boosting its footprint in the German biotechnology ecosystem. The...
Eli Lilly unites healthcare and research to create medicines that improve the lives of people around the world. Harnessing the power of biotechnology, chemistry, and genetics, its scientists are...
More than half of the population of the countries of the Organization for Economic Cooperation and Development (OECD) was overweight or obese, according to the latest...
Rovi announced that it estimates its operating income will decrease by around 10% compared to 2023. This forecast has been justified, mainly, by the fact that...
PharmaMar is a biopharmaceutical company based in Madrid, specializing in the discovery, development, and commercialization of new antitumor drugs of marine origin. The company has a...
This week the Catalan pharmaceutical company announced an annual growth of 22% in its income until the third quarter of 2023, which amounted to €237 million....
As hot no-code AI tools hit the market, non-technical entrepreneurs and businesses are spinning up AI apps faster than you can say ChatGPT. Leading the market...
As part of the transaction, Galapagos will also transfer to Alfasigma the European and U.K. marketing authorizations and related commercial, medical, and development activities, as well...